Related Experiment Videos
[Effects of clomiphene on the functions of the corpus luteum]
Zhonghua Fu Chan Ke Za Zhi
|May 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Tissue remodeling of rat pulmonary artery in hypoxic breathing. I. Changes of morphology, zero-stress state, and gene expression.
Annals of biomedical engineering·2001
Tissue remodeling of rat pulmonary artery in hypoxic breathing. II. Course of change of mechanical properties.
Annals of biomedical engineering·2001
[A study of innervation of musculus temporalis and its clinical application].
Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns·2001
[Inhibitive effect of bcl-2 antisense oligodeoxynucleotide on Bcl-2 protein synthesis and cell proliferation in human laryngocarcinoma Hep-2 cells].
Zhonghua er bi yan hou ke za zhi·2001
Incorporating language phenotypes strengthens evidence of linkage to autism.
American journal of medical genetics·2001
[A national questionnaire survey of the current status of diagnosis and treatment of endometriosis in China in 2024].
Zhonghua fu chan ke za zhi·2026
[Clinical observational study on detection and treatment of adenocarcinoma in situ of the cervix].
Zhonghua fu chan ke za zhi·2026
[Analysis of risk factors for pathological upgrading after cervical conization in patients with CIN1].
Zhonghua fu chan ke za zhi·2026
Synergistic lipase inhibition by Garcinia parvifolia metabolites: a 1H NMR-based metabolomic deciphering of ligand interactions.
Metabolomics : Official journal of the Metabolomic Society·2026
Design, synthesis, and evaluation of fluorescent probes targeting DNA polymerase theta (Polθ) for inhibitor screening and cellular imaging.
European journal of medicinal chemistry·2026
Proteolysis Targeting Chimera (PROTAC) Linkerology Enhances the CDK-Degradation Selectivity Profile of a Multi-CDK Inhibitor: Discovery of Potent, Anti-Leukemic CDK9 Degraders.
ACS pharmacology & translational science·2026